Fan Yang

5PUBLICATIONS
25CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Sep 07, 2026
Blueberry Extract Has Anti-Proliferative Activity in Preclinical Models of Head and Neck Cancer.

|Apr 28, 2025
Blocking the TCA Cycle in Cancer Cells Potentiates CD36+ T-cell-Mediated Antitumor Immunity by Suppressing ER Stress-Associated THBS2 Signaling.

Jianqiang Yang, Fanghui Chen, Zhenzhen Fu

|Jul 18, 2024
Therapeutic Targeting of the GLS1-c-Myc Positive Feedback Loop Suppresses Glutaminolysis and Inhibits Progression of Head and Neck Cancer.

Jianqiang Yang, Fanghui Chen, Liwei Lang

|Feb 23, 2024
HSP90 inhibition suppresses tumor glycolytic flux to potentiate the therapeutic efficacy of radiotherapy for head and neck cancer.

Fanghui Chen, Chris Tang, Fan Yang

|Apr 24, 2023
Adaptive c-Met-PLXDC2 Signaling Axis Mediates Cancer Stem Cell Plasticity to Confer Radioresistance-associated Aggressiveness in Head and Neck Cancer.

Liwei Lang, Fanghui Chen, Yamin Li

Pageof 1

Frequent Collaborators

5 joint publications

Nabil F Saba

5 joint publications

Yong Teng

3 joint publications

Fanghui Chen

2 joint publications

Liwei Lang